<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37751402</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-6992</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>19</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Nano letters</Title><ISOAbbreviation>Nano Lett</ISOAbbreviation></Journal><ArticleTitle>Cytoplasm Hydrogelation-Mediated Cardiomyocyte Sponge Alleviated Coxsackievirus B3 Infection.</ArticleTitle><Pagination><StartPage>8881</StartPage><EndPage>8890</EndPage><MedlinePgn>8881-8890</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.nanolett.3c01983</ELocationID><Abstract><AbstractText>Viral myocarditis (VMC), commonly caused by coxsackievirus B3 (CVB3) infection, lacks specific treatments and leads to serious heart conditions. Current treatments, such as IFNα and ribavirin, show limited effectiveness. Herein, rather than inhibiting virus replication, this study introduces a novel cardiomyocyte sponge, intracellular gelated cardiomyocytes (GCs), to trap and neutralize CVB3 via a receptor-ligand interaction, such as CAR and CD55. By maintaining cellular morphology, GCs serve as sponges for CVB3, inhibiting infection. <i>In vitro</i> results revealed that GCs could inhibit CVB3 infection on HeLa cells. <i>In vivo</i>, GCs exhibited a strong immune escape ability and effectively inhibited CVB3-induced viral myocarditis with a high safety profile. The most significant implication of this study is to develop a universal antivirus infection strategy via intracellular gelation of the host cell, which can be employed not only for treating defined pathogenic viruses but also for a rapid response to infection outbreaks caused by mutable and unknown viruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingzhe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, Shenzhen 518035, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tonggong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, Shenzhen 518035, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Siyao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Health Science and Technology, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hui-Hui</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, Shenzhen 518035, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Weidong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Health Science and Technology, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, Shenzhen 518035, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Dayong</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9547-8474</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, Shenzhen 518035, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nano Lett</MedlineTA><NlmUniqueID>101088070</NlmUniqueID><ISSNLinking>1530-6984</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020100">Hydrogels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="Y">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020100" MajorTopicYN="Y">Hydrogels</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiretroviral strategy</Keyword><Keyword MajorTopicYN="N">cellular sponge</Keyword><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">hydrogel</Keyword><Keyword MajorTopicYN="N">virus neutralization</Keyword></KeywordList><CoiStatement>The authors
declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37751402</ArticleId><ArticleId IdType="pmc">PMC10573321</ArticleId><ArticleId IdType="doi">10.1021/acs.nanolett.3c01983</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stone V. M.; Hankaniemi M. M.; Laitinen O. H.; Sioofy-Khojine A. B.; Lin A.; Diaz Lozano I. M.; Mazur M. A.; Marjomaki V.; Lore K.; Hyoty H.; et al. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci. Adv. 2020, 6 (19), eaaz243310.1126/sciadv.aaz2433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz2433</ArticleId><ArticleId IdType="pmc">PMC7202868</ArticleId><ArticleId IdType="pubmed">32494709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih W. L.; Tung Y. C.; Chang L. Y.; Fang C. T.; Tsai W. Y. Increased Incidence of Pediatric Type 1 Diabetes With Novel Association With Coxsackievirus A Species in Young Children but Declined Incidence in Adolescents in Taiwan. Diabetes Care 2021, 44 (7), 1579–1585. 10.2337/dc20-1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1092</ArticleId><ArticleId IdType="pmc">PMC8323190</ArticleId><ArticleId IdType="pubmed">34083323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard N. L.; Zhang L.; Chen J. W.; Guttenberg M.; Sanchez M. D.; Bergelson J. M. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 2009, 6 (1), 91–98. 10.1016/j.chom.2009.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.05.018</ArticleId><ArticleId IdType="pmc">PMC2761025</ArticleId><ArticleId IdType="pubmed">19616768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y.; Tang H.; Xue Y. C.; Liu H.; Ng C. S.; Bahreyni A.; Luo H. Coxsackievirus B3 targets TFEB to disrupt lysosomal function. Autophagy 2021, 17 (12), 3924–3938. 10.1080/15548627.2021.1896925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1896925</ArticleId><ArticleId IdType="pmc">PMC8726691</ArticleId><ArticleId IdType="pubmed">33691586</ArticleId></ArticleIdList></Reference><Reference><Citation>Weithauser A.; Bobbert P.; Antoniak S.; Bohm A.; Rauch B. H.; Klingel K.; Savvatis K.; Kroemer H. K.; Tschope C.; Stroux A.; et al. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J. Am. Coll Cardiol 2013, 62 (19), 1737–1745. 10.1016/j.jacc.2013.05.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.05.076</ArticleId><ArticleId IdType="pmc">PMC4077621</ArticleId><ArticleId IdType="pubmed">23871888</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivadeneyra L.; Charo N.; Kviatcovsky D.; de la Barrera S.; Gomez R. M.; Schattner M. Role of neutrophils in CVB3 infection and viral myocarditis. J. Mol. Cell Cardiol 2018, 125, 149–161. 10.1016/j.yjmcc.2018.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2018.08.029</ArticleId><ArticleId IdType="pubmed">30393107</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.; Wang X.; Kapteijn F. Water and Metal-Organic Frameworks: From Interaction toward Utilization. Chem. Rev. 2020, 120 (16), 8303–8377. 10.1021/acs.chemrev.9b00746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.9b00746</ArticleId><ArticleId IdType="pmc">PMC7453405</ArticleId><ArticleId IdType="pubmed">32412734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sainz B. Jr.; Barretto N.; Martin D. N.; Hiraga N.; Imamura M.; Hussain S.; Marsh K. A.; Yu X.; Chayama K.; Alrefai W. A.; et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 2012, 18 (2), 281–285. 10.1038/nm.2581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2581</ArticleId><ArticleId IdType="pmc">PMC3530957</ArticleId><ArticleId IdType="pubmed">22231557</ArticleId></ArticleIdList></Reference><Reference><Citation>Voros J.; Urbanek A.; Rautureau G. J.; O’Connor M.; Fisher H. C.; Ashcroft A. E.; Ferguson N. Large-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase. J. Virol 2014, 88 (5), 2584–2599. 10.1128/JVI.02575-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02575-13</ArticleId><ArticleId IdType="pmc">PMC3958071</ArticleId><ArticleId IdType="pubmed">24352439</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt F.; Weisblum Y.; Muecksch F.; Hoffmann H. H.; Michailidis E.; Lorenzi J. C. C.; Mendoza P.; Rutkowska M.; Bednarski E.; Gaebler C.; et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J. Exp Med. 2020, 217 (11), e2020118110.1084/jem.20201181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201181</ArticleId><ArticleId IdType="pmc">PMC7372514</ArticleId><ArticleId IdType="pubmed">32692348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi X.; Liu X.; Wang C.; Zhang X.; Li X.; Hou J.; Ren L.; Jin Q.; Wang J.; Yang W. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain. Nat. Commun. 2020, 11 (1), 4528.10.1038/s41467-020-18387-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18387-8</ArticleId><ArticleId IdType="pmc">PMC7483421</ArticleId><ArticleId IdType="pubmed">32913273</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.; Yu D.; Wu X.; Liang H.; Zhou Z.; Xie Y.; Li T.; Wu J.; Lu F.; Feng L.; et al. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nat. Commun. 2021, 12 (1), 4144.10.1038/s41467-021-24230-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24230-5</ArticleId><ArticleId IdType="pmc">PMC8260809</ArticleId><ArticleId IdType="pubmed">34230476</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer G.; Struck F.; Staschik E.; Maile J.; Wochinz-Richter K.; Motz M.; Soutschek E. Differential avidity determination of IgG directed towards the receptor-binding domain (RBD) of SARS-CoV-2 wild-type and its variants in one assay: Rational tool for the assessment of protective immunity. J. Med. Virol 2022, 94 (11), 5294–5303. 10.1002/jmv.28006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28006</ArticleId><ArticleId IdType="pmc">PMC9349558</ArticleId><ArticleId IdType="pubmed">35851961</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanke L.; Das H.; Sheward D. J.; Perez Vidakovics L.; Urgard E.; Moliner-Morro A.; Kim C.; Karl V.; Pankow A.; Smith N. L.; et al. A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo. Nat. Commun. 2022, 13 (1), 155.10.1038/s41467-021-27610-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27610-z</ArticleId><ArticleId IdType="pmc">PMC8748511</ArticleId><ArticleId IdType="pubmed">35013189</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X.; Wen F.; Zheng N.; Saive M.; Fauconnier M. L.; Wang J. Aptamer-Based Biosensor for Detection of Mycotoxins. Front Chem. 2020, 8, 195.10.3389/fchem.2020.00195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2020.00195</ArticleId><ArticleId IdType="pmc">PMC7186343</ArticleId><ArticleId IdType="pubmed">32373573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S. P.; Ruffolo J. A.; Frick R.; Gray J. J. Hallucinating structure-conditioned antibody libraries for target-specific binders. Front Immunol 2022, 13, 999034.10.3389/fimmu.2022.999034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.999034</ArticleId><ArticleId IdType="pmc">PMC9635398</ArticleId><ArticleId IdType="pubmed">36341416</ArticleId></ArticleIdList></Reference><Reference><Citation>Stergioti E. M.; Manolakou T.; Boumpas D. T.; Banos A. Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting. Biomedicines 2022, 10 (11), 2820.10.3390/biomedicines10112820.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10112820</ArticleId><ArticleId IdType="pmc">PMC9687478</ArticleId><ArticleId IdType="pubmed">36359340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.; Li X.; Cai Q.; Li C.; Tian L.; Chen J.; Xing X.; Gan Y.; Ouyang W.; Yang Z. The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells. Int. J. Mol. Med. 2017, 40 (1), 182–192. 10.3892/ijmm.2017.3008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.3008</ArticleId><ArticleId IdType="pmc">PMC5466389</ArticleId><ArticleId IdType="pubmed">28560385</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.; Zheng Q.; Zhu R.; Yin Z.; Yu H.; Lin Y.; Wu Y.; He M.; Huang Y.; Jiang Y.; et al. Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating. Cell Host Microbe 2021, 29 (3), 448–462. 10.1016/j.chom.2021.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.01.001</ArticleId><ArticleId IdType="pmc">PMC8310385</ArticleId><ArticleId IdType="pubmed">33539764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicmal T. M.; Tate P. M.; Dial C. N.; Esin J. J.; Mounce B. C. Polyamine Depletion Abrogates Enterovirus Cellular Attachment. J. Virol 2019, 93 (20), 01054-0101910.1128/JVI.01054-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01054-19</ArticleId><ArticleId IdType="pmc">PMC6798109</ArticleId><ArticleId IdType="pubmed">31341056</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P.; Perera R.; Cardosa J.; Kuhn R. J.; Rossmann M. G. Crystal structure of human enterovirus 71. Science 2012, 336 (6086), 1274.10.1126/science.1218713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C.; Huang Q.; Liu C.; Kwong C. H. T.; Yue L.; Wan J. B.; Lee S. M. Y.; Wang R. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 2020, 11 (1), 2622.10.1038/s41467-020-16439-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16439-7</ArticleId><ArticleId IdType="pmc">PMC7251120</ArticleId><ArticleId IdType="pubmed">32457361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.; Chen M.; Zhang Y.; Lee J. H.; Escajadillo T.; Gong H.; Fang R. H.; Gao W.; Nizet V.; Zhang L. Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges. Adv. Healthc Mater. 2018, 7 (13), 170136610.1002/adhm.201701366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adhm.201701366</ArticleId><ArticleId IdType="pmc">PMC6041168</ArticleId><ArticleId IdType="pubmed">29436150</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao L.; Wang W.; Meng Q. F.; Tian M.; Cai B.; Wang Y.; Li A.; Zan M.; Xiao F.; Bu L. L.; et al. A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly Development. Nano Lett. 2019, 19 (4), 2215–2222. 10.1021/acs.nanolett.8b03913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.8b03913</ArticleId><ArticleId IdType="pubmed">30543300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X.; Zhang G.; Ran D.; Krishnan N.; Fang R. H.; Gao W.; Spector S. A.; Zhang L. T-Cell-Mimicking Nanoparticles Can. Neutralize HIV Infectivity. Adv. Mater. 2018, 30 (45), 180223310.1002/adma.201802233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.201802233</ArticleId><ArticleId IdType="pmc">PMC6334303</ArticleId><ArticleId IdType="pubmed">30252965</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymans S.; Eriksson U.; Lehtonen J.; Cooper L. T. Jr. The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. J. Am. Coll Cardiol 2016, 68 (21), 2348–2364. 10.1016/j.jacc.2016.09.937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.09.937</ArticleId><ArticleId IdType="pubmed">27884253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennerfeldt D. A.; Renth A. N.; Talata Z.; Gehrke S. H.; Detamore M. S. Tuning mechanical performance of poly(ethylene glycol) and agarose interpenetrating network hydrogels for cartilage tissue engineering. Biomaterials 2013, 34 (33), 8241–8257. 10.1016/j.biomaterials.2013.07.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2013.07.052</ArticleId><ArticleId IdType="pmc">PMC3773240</ArticleId><ArticleId IdType="pubmed">23932504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ci T.; Li H.; Chen G.; Wang Z.; Wang J.; Abdou P.; Tu Y.; Dotti G.; Gu Z. Cryo-shocked cancer cells for targeted drug delivery and vaccination. Sci. Adv. 2020, 6 (50), eabc301310.1126/sciadv.abc3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc3013</ArticleId><ArticleId IdType="pmc">PMC7725453</ArticleId><ArticleId IdType="pubmed">33298439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y.; Ren J.; Dong X.; Zhang D.; Qu Y.; Yang C.; Sun Y.; Li J.; Luo F.; Wang W.; et al. Fulminant Giant Cell Myocarditis vs. Lymphocytic Myocarditis: A Comparison of Their Clinical Characteristics, Treatments, and Outcomes. Front Cardiovasc Med. 2021, 8, 770549.10.3389/fcvm.2021.770549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.770549</ArticleId><ArticleId IdType="pmc">PMC8678080</ArticleId><ArticleId IdType="pubmed">34926619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y.; Gong X.; Qin D.; Cao Y.; Zhang S.; Xia L.; Liu F.; Su Z. S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. J. Leukoc Biol. 2023, 114 (2), 154–163. 10.1093/jleuko/qiad048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jleuko/qiad048</ArticleId><ArticleId IdType="pubmed">37141387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H. S.; Kang N. W.; Kim H.; Kim D. H.; Chae J. W.; Lee W.; Song G. Y.; Cho C. W.; Kim D. D.; Lee J. Y. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel. Carbohydr. Polym. 2021, 253, 117187.10.1016/j.carbpol.2020.117187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2020.117187</ArticleId><ArticleId IdType="pubmed">33278965</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.; Yang Y.; Zheng H.; Huang C.; Zhu X.; Zhu Y.; Guan R.; Xin Z.; Liu Z.; Tian Y. Intracavernous injection of size-specific stem cell spheroids for neurogenic erectile dysfunction: Efficacy and risk versus single cells. EBioMedicine 2020, 52, 102656.10.1016/j.ebiom.2020.102656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102656</ArticleId><ArticleId IdType="pmc">PMC7016386</ArticleId><ArticleId IdType="pubmed">32062355</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao M.; Tian F.; Liu X.; Zhou Q.; Pan J.; Luo Z.; Yang M.; Yi C. Virus Detection: From State-of-the-Art Laboratories to Smartphone-Based Point-of-Care Testing. Adv. Sci. (Weinh) 2022, 9 (17), e210590410.1002/advs.202105904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202105904</ArticleId><ArticleId IdType="pmc">PMC9110880</ArticleId><ArticleId IdType="pubmed">35393791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q.; Honko A.; Zhou J.; Gong H.; Downs S. N.; Vasquez J. H.; Fang R. H.; Gao W.; Griffiths A.; Zhang L. Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity. Nano Lett. 2020, 20 (7), 5570–5574. 10.1021/acs.nanolett.0c02278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.0c02278</ArticleId><ArticleId IdType="pmc">PMC7301960</ArticleId><ArticleId IdType="pubmed">32551679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.; Wang D.; Duan Y.; Zhou Z.; Gao W.; Zhang L. Cellular Nanosponges for Biological Neutralization. Adv. Mater. 2022, 34 (13), e210771910.1002/adma.202107719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202107719</ArticleId><ArticleId IdType="pubmed">34783078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza R.; Russell D. W.; Nagy A. Engineering universal cells that evade immune detection. Nat. Rev. Immunol 2019, 19 (12), 723–733. 10.1038/s41577-019-0200-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0200-1</ArticleId><ArticleId IdType="pubmed">31417198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredericksen B. L.; Wei B. L.; Yao J.; Luo T.; Garcia J. V. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol 2002, 76 (22), 11440–11446. 10.1128/JVI.76.22.11440-11446.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.22.11440-11446.2002</ArticleId><ArticleId IdType="pmc">PMC136743</ArticleId><ArticleId IdType="pubmed">12388705</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W.; Zhang Y.; Zhang Q.; Zhang L. Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery. Ann. Biomed Eng. 2016, 44 (6), 2049–2061. 10.1007/s10439-016-1583-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10439-016-1583-9</ArticleId><ArticleId IdType="pmc">PMC4880511</ArticleId><ArticleId IdType="pubmed">26951462</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>